Neukio Biotherapeutics
Shanghai
About Neukio Biotherapeutics
Neukio Biotherapeutics is an immune cell drug developer, focusing on the research and development and industrialization of immune cell drugs, developing iPSC-CAR-NK general-purpose spot immune cell products, and is committed to providing effective therapeutic drugs for cancer patients around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $90.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2022)
- Website: neukio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/neukio-biotherapeutics-26057 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.